Brawn Biotech Financials

BSE: 530207

₹22.70

₹0.10 (0.44%)

As on 04-Sep-2026IST

Market cap

₹7 Cr

Revenue (TTM)

₹17 Cr

P/E Ratio

7.9

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	17.26	13.46	16.49	22.23	8.62	34.98
Total Income	17.76	13.56	16.58	22.24	8.62	35.28
Total Expenditure	17.72	15.24	17.97	22.53	10.63	35.57
EBITDA	-0.46	-1.77	-1.47	-0.30	-2.01	-0.60
Depreciation	0.12	0.11	0.10	0.11	0.05	0.03
EBIT	-0.58	-1.89	-1.57	-0.41	-2.06	-0.63
Interest	0.00	0.00	0.06	0.01	0.06	0.04
Other Income	0.50	0.09	0.09	0.01	0.00	0.31
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.08	-1.80	-1.54	-0.41	-2.12	-0.36
Provision for Tax	-0.94	-0.06	-0.30	0.46	-0.47	0.19
Profit after Tax	0.86	-1.74	-1.25	-0.87	-1.64	-0.55

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	4.34	3.36	5.07	6.31	7.22	8.80
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.35	7.29	2.56	0.02	-0.38	0.03
Current Liabilities	15.17	9.33	6.51	8.05	6.32	4.90
Total Liabilities	20.86	20.49	14.59	14.53	13.78	13.87

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	1.82	2.47	0.99	0.97	0.97	1.00
Current Assets	17.12	17.50	13.14	13.40	12.19	12.73
Total Assets	20.86	20.49	14.59	14.53	13.78	13.87
Total Debt*	--	--	--	--	--	--
Net Current Assets	1.95	8.17	6.63	5.35	5.87	7.82
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	0.05	-0.03	0.32	0.19	0.03
Cash Flow from Investing Activities	--	-0.24	-0.01	-0.10	-0.30	--
Cash from Financing Activities	--	0.00	0.00	-0.01	-0.06	-0.04
Net Cash Inflow / Outflow	--	-0.20	-0.04	0.21	-0.17	0.00

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	2.86	-5.80	-4.16	-2.89	-5.48	-1.84
Cash EPS (₹)	2.86	-5.42	-3.83	-2.53	-5.30	-1.72
Adjusted Book Value (₹)	14.98	11.21	16.88	21.03	24.07	29.31
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.16	-0.09	1.06	0.63	0.11
Free Cash Flow per Share (₹)	--	-0.59	0.84	-0.69	0.77	-0.01

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	-42.59	-26.12	-5.94	-25.66	-3.57
ROE (%)	21.33	-41.30	-21.93	-12.83	-20.53	-6.10
ROA (%)	4.15	-10.20	-8.75	-6.31	-12.23	-3.24
EBIT Margin (%)	-3.35	-14.02	-9.54	-1.85	-23.88	-1.81
Net Margin (%)	4.83	-12.83	-7.52	-3.90	-19.07	-1.56
Cash Profit Margin (%)	0.00	-12.07	-6.96	-3.41	-18.46	-1.48

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-7.77	-18.37	-25.80	157.88	-75.35	-29.51
EBIT Growth (%)	-358.48	-19.95	-282.63	80.02	-225.95	-190.04
Net Profit Growth (%)	12.30	-39.54	-43.64	47.21	-198.65	-193.13
EPS Growth (%)	12.30	-39.54	-43.64	47.21	-198.64	-193.12
Book Value Growth (%)	--	-33.62	-19.72	-12.62	-17.90	-5.03

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	7.94	--	--	--	--	--
Price / Book Value	1.52	1.45	1.18	0.79	0.72	0.75
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	151.85	-2.78	-4.04	-15.45	-2.49	-21.60
Close Price (₹)	20.50	16.25	20.00	16.55	17.35	22.10
High Price (₹)	24.37	27.82	26.80	22.85	43.75	32.00
Low Price (₹)	16.66	15.46	14.36	13.60	16.90	17.75
Market Cap (₹ Cr)	6.81	4.88	6.00	4.97	5.21	6.63

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	1.13	1.88	2.02	1.67	1.93	2.60
Quick Ratio	0.47	0.76	1.11	1.18	1.20	2.63
Interest Coverage	-19.50	-489.74	-25.42	-42.63	-32.60	-8.55

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	20.56	25.35	23.54	23.91	32.59	26.53
Asset Turnover	0.83	0.79	1.16	1.61	0.64	2.06
Receivable days	--	98.89	101.77	66.70	255.91	126.66
Inventory Days	--	223.41	119.58	78.11	105.44	3.37
Payable days	--	212.83	154.30	100.12	185.95	68.36
Cash Conversion Cycle	--	109.48	67.06	44.69	175.40	61.67

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.